| Actinomyces viscosus |
Actinomyces viscosus |
MIC |
15.0 |
ug.mL-1 |
10.1021/np960451q |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
10000.0 |
nM |
None |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
15848.9 |
nM |
None |
| Bacillus pumilus |
Bacillus pumilus |
MBC |
32.0 |
ug ml-1 |
10.1016/j.ejmech.2021.113723 |
| Bacillus pumilus |
Bacillus pumilus |
MIC |
4.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Bacillus pumilus |
Bacillus pumilus |
Ratio |
8.0 |
None |
10.1016/j.ejmech.2021.113723 |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
8912.5 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
10000.0 |
nM |
None |
| Bacillus subtilis |
Bacillus subtilis |
Activity |
nan |
None |
10.1039/c2md20127e |
| Bacillus subtilis |
Bacillus subtilis |
MBC |
128.0 |
ug ml-1 |
10.1016/j.ejmech.2021.113723 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
8.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
10000.0 |
nM |
10.1039/c2md20127e |
| Bacillus subtilis (strain 168) |
DNA polymerase III |
Potency |
8436.8 |
nM |
None |
| Cavia porcellus |
Cavia porcellus |
Relaxation |
-89.0 |
% |
10.1016/s0960-894x(98)00056-0 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
26.96 |
% |
10.1016/j.bmc.2012.09.040 |
| Enterococcus faecalis |
Enterococcus faecalis |
MBC |
64.0 |
ug ml-1 |
10.1016/j.ejmech.2021.113723 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
8.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.12.027 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
16.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.12.027 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
16.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
32.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC=>90 |
8.0 |
ug ml-1 |
10.1016/j.bmcl.2013.02.016 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC=>90 |
16.0 |
ug ml-1 |
10.1016/j.bmcl.2013.02.016 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC90 |
8.0 |
ug.mL-1 |
10.1016/j.bmc.2012.10.009 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC90 |
16.0 |
ug.mL-1 |
10.1016/j.bmc.2012.10.009 |
| Enterococcus faecium |
Enterococcus faecium |
MBC |
64.0 |
ug ml-1 |
10.1016/j.ejmech.2021.113723 |
| Enterococcus faecium |
Enterococcus faecium |
MIC |
32.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Enterococcus faecium |
Enterococcus faecium |
MIC |
64.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Equus caballus |
Cholinesterase |
Inhibition |
1.3 |
% |
10.1016/j.bmc.2012.09.040 |
| Escherichia coli |
Escherichia coli |
MIC |
32.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Escherichia coli |
Escherichia coli |
MIC |
128.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| Escherichia coli K-12 |
Cell division protein ftsZ |
IC50 |
3000.0 |
nM |
10.1016/j.ejmech.2020.112132 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
6294.6 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
78 kDa glucose-regulated protein |
Potency |
4140.0 |
nM |
None |
| Homo sapiens |
78 kDa glucose-regulated protein |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
A549 |
IC50 |
610.0 |
nM |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
1220.0 |
nM |
10.1016/j.ejmech.2020.112415 |
| Homo sapiens |
Acetylcholinesterase |
Inhibition |
91.2 |
% |
10.1016/j.ejmech.2020.112415 |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Alpha-synuclein |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Alpha-synuclein |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Arachidonate 12-lipoxygenase |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Arachidonate 12-lipoxygenase |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
580.2 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
2908.1 |
nM |
None |
| Homo sapiens |
Bcl2-antagonist of cell death (BAD) |
IC50 |
19000.0 |
nM |
10.1021/jm8005433 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
7080.0 |
nM |
10.1016/j.ejmech.2020.112415 |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
21331.3 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
9466.2 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
3981.07 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
3162.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
6309.57 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
15848.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
7943.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
31622.78 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
3162.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
DNA dC->dU-editing enzyme APOBEC-3G |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
4610.9 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Fibrinogen beta chain |
IC50 |
24165.0 |
nM |
None |
| Homo sapiens |
Fibrinogen beta chain |
IC50 |
83135.0 |
nM |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
26679.5 |
nM |
None |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Guanine nucleotide-binding protein G(i) subunit alpha-1/Regulator of G-protein signaling 12 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
HEK293 |
Activity |
nan |
None |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
HEK293 |
Potency |
1031.8 |
nM |
None |
| Homo sapiens |
HepG2 |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
8.0 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
26.78 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
1888.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Huntingtin |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Mothers against decapentaplegic homolog 3 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
145809.7 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
18356.4 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B complex |
IC50 |
2000.0 |
nM |
10.1016/j.bmc.2014.03.046 |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
PC-3 |
GI |
nan |
None |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Prelamin-A/C |
Potency |
398.1 |
nM |
None |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
46109.1 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 12 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 17 |
Activity |
16234.0 |
Da |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Regulator of G-protein signaling 17 |
Activity |
nan |
None |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Regulator of G-protein signaling 17 |
IC50 |
12000.0 |
nM |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Regulator of G-protein signaling 17 |
IC50 |
72800.0 |
nM |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Regulator of G-protein signaling 17 |
IC50 |
100000.0 |
nM |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Regulator of G-protein signaling 17 |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Regulator of G-protein signaling 17 |
Kd |
1000.0 |
nM |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
2119.2 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
RWPE-1 |
GI |
nan |
None |
10.1021/acs.jnatprod.7b00112 |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
3288.5 |
nM |
None |
| Homo sapiens |
SH-SY5Y |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Signal transducer and activator of transcription 6 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Signal transducer and activator of transcription 6 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
-0.2 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
2.9 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
15.0 |
% |
10.1021/jm300212s |
| Homo sapiens |
Survival motor neuron protein |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Survival motor neuron protein |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
T-24 |
Activity |
639.2 |
U/mg |
10.1016/j.ejmech.2010.10.006 |
| Homo sapiens |
Thrombopoietin |
Potency |
1000.0 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Tumor susceptibility gene 101 protein |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
580.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
819.9 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 2 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
35481.3 |
nM |
None |
| Leishmania mexicana |
Pyruvate kinase |
Potency |
10000.0 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
3162.3 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
6309.6 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
7079.5 |
nM |
None |
| Mycolicibacterium aurum |
Mycolicibacterium aurum |
MIC |
24.5 |
ug.mL-1 |
10.1016/j.ejmech.2022.114173 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
24.5 |
ug.mL-1 |
10.1016/j.ejmech.2022.114173 |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
7208.0 |
nM |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
12589.3 |
nM |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
15848.9 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
6745.6 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
16944.1 |
nM |
None |
| Porphyromonas gingivalis |
Porphyromonas gingivalis |
MIC |
2.0 |
ug.mL-1 |
10.1021/np960451q |
| Porphyromonas gingivalis |
Porphyromonas gingivalis |
MIC |
15.0 |
ug.mL-1 |
10.1021/np970524l |
| Prevotella intermedia |
Prevotella intermedia |
MIC |
2.0 |
ug.mL-1 |
10.1021/np960451q |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
64.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
128.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| Rattus norvegicus |
Alanine aminotransferase |
Concentration |
5e-05 |
M |
10.1021/jm00141a019 |
| Rattus norvegicus |
Alanine aminotransferase |
ID50 |
3.4e-06 |
M |
10.1021/jm00141a019 |
| Rattus norvegicus |
Alanine aminotransferase |
Inhibition |
15.0 |
% |
10.1021/jm00141a019 |
| Rattus norvegicus |
Alanine aminotransferase |
Inhibition |
20.0 |
% |
10.1021/jm00141a019 |
| Rattus norvegicus |
Alanine aminotransferase |
Inhibition |
74.0 |
% |
10.1021/jm00141a019 |
| Rattus norvegicus |
Alanine aminotransferase |
Protection |
5.0 |
% |
10.1021/jm00141a019 |
| Rattus norvegicus |
Alanine aminotransferase |
Protection |
75.0 |
% |
10.1021/jm00141a019 |
| Rattus norvegicus |
Alanine aminotransferase |
Protection |
81.0 |
% |
10.1021/jm00141a019 |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
10000.0 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
141.3 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
12589.3 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
8087.5 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
15836.9 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
31622.8 |
nM |
None |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
461.1 |
nM |
None |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1016/j.bmc.2011.11.052 |
| Staphylococcus aureus |
Staphylococcus aureus |
EC50 |
24500.0 |
nM |
10.1016/j.bmc.2011.11.052 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBC |
34.0 |
uM |
10.1016/j.bmc.2011.11.052 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBC |
64.0 |
ug ml-1 |
10.1016/j.ejmech.2021.113723 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBC |
128.0 |
ug ml-1 |
10.1016/j.ejmech.2021.113723 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.12.027 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
4.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
4.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
8.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
8.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
16.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
34000.0 |
nM |
10.1016/j.bmc.2011.11.052 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC=>90 |
2.0 |
ug ml-1 |
10.1016/j.bmcl.2013.02.016 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC90 |
2.0 |
ug.mL-1 |
10.1016/j.bmc.2012.10.009 |
| Staphylococcus aureus |
Staphylococcus aureus |
Ratio |
16.0 |
None |
10.1016/j.ejmech.2021.113723 |
| Staphylococcus aureus |
Staphylococcus aureus |
Ratio |
32.0 |
None |
10.1016/j.ejmech.2021.113723 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Activity |
nan |
None |
10.1016/j.bmc.2011.11.052 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
EC50 |
4400.0 |
nM |
10.1016/j.bmc.2011.11.052 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MBC |
34.0 |
uM |
10.1016/j.bmc.2011.11.052 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
8.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
64.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
8500.0 |
nM |
10.1016/j.bmc.2011.11.052 |
| Streptococcus mutans |
Streptococcus mutans |
MIC |
15.0 |
ug.mL-1 |
10.1021/np960451q |
| Streptococcus mutans |
Streptococcus mutans |
MIC |
15.0 |
ug.mL-1 |
10.1021/np970524l |
| Streptococcus pyogenes |
Streptococcus pyogenes |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.113723 |
| Streptococcus pyogenes |
Streptococcus pyogenes |
MIC |
8.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
47.8 |
nM |
None |
| None |
ADMET |
Log K |
2.97 |
None |
10.1021/jm00141a019 |
| None |
ADMET |
Log K |
3.33 |
None |
10.1021/jm00141a019 |
| None |
ADMET |
Log K |
3.77 |
None |
10.1021/jm00141a019 |
| None |
ADMET |
Log K |
4.01 |
None |
10.1021/jm00141a019 |
| None |
ADMET |
Log K |
4.64 |
None |
10.1021/jm00141a019 |
| None |
ADMET |
Log K |
4.79 |
None |
10.1021/jm00141a019 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1039/C3MD00149K |
| None |
NON-PROTEIN TARGET |
EC50 |
890.0 |
nM |
10.1039/C3MD00149K |
| None |
NON-PROTEIN TARGET |
EC50 |
930.0 |
nM |
10.1039/C3MD00149K |
| None |
NON-PROTEIN TARGET |
EC50 |
1000.0 |
nM |
10.1039/C3MD00149K |
| None |
NON-PROTEIN TARGET |
GI |
88.5 |
% |
10.1016/j.bmcl.2016.11.031 |
| None |
NON-PROTEIN TARGET |
GI |
92.3 |
% |
10.1016/j.bmcl.2016.11.031 |
| None |
NON-PROTEIN TARGET |
IC50 |
530.0 |
nM |
10.1016/j.bmcl.2016.11.031 |
| None |
NON-PROTEIN TARGET |
IC50 |
1510.0 |
nM |
10.1016/j.bmcl.2016.11.031 |
| None |
No relevant target |
Activity |
nan |
None |
10.1021/acs.jnatprod.7b00112 |
| None |
No relevant target |
EC50 |
513000.0 |
nM |
10.1039/C3MD00149K |
| None |
Unchecked |
Ac50 |
17.78 |
uM |
None |
| None |
Unchecked |
AC50 |
17782.8 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmc.2020.115732 |
| None |
Unchecked |
FC |
18.0 |
None |
10.1016/j.ejmech.2017.06.047 |
| None |
Unchecked |
FC |
35.0 |
None |
10.1016/j.ejmech.2017.06.047 |
| None |
Unchecked |
GI |
nan |
None |
10.1021/acs.jnatprod.7b00112 |
| None |
Unchecked |
IC50 |
264.6 |
nM |
None |
| None |
Unchecked |
IC50 |
316.1 |
nM |
None |
| None |
Unchecked |
IC50 |
349.8 |
nM |
None |
| None |
Unchecked |
IC50 |
378.9 |
nM |
None |
| None |
Unchecked |
IC50 |
525.3 |
nM |
None |
| None |
Unchecked |
IC50 |
537.2 |
nM |
None |
| None |
Unchecked |
IC50 |
575.5 |
nM |
None |
| None |
Unchecked |
IC50 |
970.46 |
nM |
None |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2020.112855 |
| None |
Unchecked |
IC50 |
40000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
51832.0 |
nM |
None |
| None |
Unchecked |
IC50 |
121805.0 |
nM |
None |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.7b00112 |
| None |
Unchecked |
MIC |
8.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| None |
Unchecked |
MIC |
128.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.06.005 |
| None |
Unchecked |
Potency |
1299.5 |
nM |
None |
| None |
Unchecked |
Potency |
1834.9 |
nM |
None |
| None |
Unchecked |
Potency |
1995.3 |
nM |
None |
| None |
Unchecked |
Potency |
2511.9 |
nM |
None |
| None |
Unchecked |
Potency |
3162.3 |
nM |
None |
| None |
Unchecked |
Potency |
3219.7 |
nM |
None |
| None |
Unchecked |
Potency |
5011.9 |
nM |
None |
| None |
Unchecked |
Potency |
7307.8 |
nM |
None |
| None |
Unchecked |
Potency |
8912.5 |
nM |
None |
| None |
Unchecked |
Potency |
14125.4 |
nM |
None |
| None |
Unchecked |
Potency |
25118.9 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Ratio |
4.0 |
None |
10.1016/j.bmc.2011.11.052 |
| None |
Unchecked |
Selectivity Index |
5.8 |
None |
10.1016/j.ejmech.2020.112415 |